Please Note: This trial is no longer enrolling new participants
Novel Targeting of the Microenvironment to Decrease Metastatic Recurrence of High-Risk TNBC: A Randomized Phase II Study of Tetrathiomolybdate (TM) Plus Capecitabine in Patients with Breast Cancer at High Risk of Recurrence
| Protocol No. | CTO-22VAH837 | Scope | National |
|---|---|---|---|
| Principal Investigator | Bryan Schneider | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase I/II |
